Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 2.91% | 69.00 | 0.0% | $1792.09m | |
| GILD | Gilead Sciences, Inc. | -0.22% | 73.34 | 1.0% | $1310.05m | |
| AMGN | Amgen, Inc. | 0.73% | 226.43 | 1.3% | $654.36m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 1.59% | 569.91 | 2.5% | $571.28m | |
| NVAX | Novavax, Inc. | -7.91% | 46.11 | 102.0% | $561.17m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 0.12% | 284.96 | 1.9% | $530.07m | |
| BIIB | Biogen, Inc. | 0.02% | 304.53 | 1.6% | $421.31m | |
| ILMN | Illumina, Inc. | 1.51% | 354.70 | 3.5% | $346.79m | |
| SRNE | Sorrento Therapeutics, Inc. | 0.80% | 5.07 | 1.8% | $295.47m | |
| SGEN | Seattle Genetics, Inc. | 1.02% | 155.77 | 6.1% | $235.46m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.36% | 101.50 | 2.0% | $221.68m | |
| MGNX | MacroGenics, Inc. | 0.84% | 25.37 | 6.2% | $199.40m | |
| CODX | Co-Diagnostics, Inc. | 2.94% | 18.55 | 0.0% | $198.21m | |
| A | Agilent Technologies, Inc. | 5.24% | 84.98 | 1.6% | $189.94m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 2.80% | 97.51 | 4.3% | $148.95m |
Company Profile
SELLAS Life Sciences Group, Inc. engages in the development and commercialization of immunotherapeutics for cancer indications. Its product pipeline includes galinpepimut-S and nelipepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.